Showing results (111-120 of 119) with videos related to

Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 119 results.
Journal of Neurology|April 12, 2006
Profound midbrain atrophy in patients with Wilson's disease and neurological symptoms?K Strecker, J P Schneider, H Barthel, et al.
Langenbecks Archiv Fur Chirurgie|January 1, 1980
[Surgical treatment of congenital heart disease in infants without use of extracorporeal circulation (author's transl)]B Rigler, J Kraft-Kinz, W Hermann, et al.
Lung Cancer (Amsterdam, Netherlands)|July 5, 2005
The retinoid X receptor agonist bexarotene (Targretin) synergistically enhances the growth inhibitory activity of cytotoxic drugs in non-small cell lung cancer cellsThomas W Hermann, Wan-Ching Yen, Patricia Tooker, et al.
Parkinsonism & Related Disorders|May 23, 2022
Association between probable REM sleep behavior disorder and increased dermal alpha-synuclein deposition in Parkinson's diseaseK Doppler, S Mammadova, A Kuzkina, et al.
World Journal of Urology|February 25, 2014
Single-Incision Transumbilical Surgery (SITUS) versus Single-Port Laparoscopic Surgery and conventional laparoscopic surgery: a prospective randomized comparative study of performance with novices in a dry laboratoryMartin Schoenthaler, Tuba Avcil, Sabina Sevcenco, et al.
Archives of Rheumatology|December 4, 2023
Towards a consensus on the clinical applications and interpretations of the nailfold capillaroscopy standards in clinical practice: An initiative by the Egyptian Society of MicrocirculationYasser El Miedany, Sherif Ismail, Mary Wadie Fawzy, et al.
Anticancer Research|July 9, 2011
Identification of polymorphisms associated with hypertriglyceridemia and prolonged survival induced by bexarotene in treating non-small cell lung cancerWen Luo, Nicholas J Schork, Keith B Marschke, et al.
Zeitschrift Fur Rheumatologie|April 19, 2020
[A cross sectional study on patients with inflammatory rheumatic diseases in terms of their compliance to their immunsuppressive medication during COVID-19 pandemic]T Schmeiser, M Broll, A Dormann, et al.
Rheumatology (Oxford, England)|March 11, 2021
The influence of the SARS-CoV-2 lockdown on patients with inflammatory rheumatic diseases on their adherence to immunomodulatory medication: a cross sectional study over 3 months in GermanyR Hasseli, U Müller-Ladner, F Keil, et al.
Pageof 12